Eleonora Toffoletti

586 total citations
19 papers, 332 citations indexed

About

Eleonora Toffoletti is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eleonora Toffoletti has authored 19 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eleonora Toffoletti's work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Eleonora Toffoletti is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Eleonora Toffoletti collaborates with scholars based in Italy, Austria and Slovenia. Eleonora Toffoletti's co-authors include Renato Fanin, Erica Simeone, Anna Candoni, Angela Michelutti, Mario Tiribelli, Corrado Pipan, Daniela Damiani, Daniela Cilloni, Giuseppe Saglio and Francesca Patriarca and has published in prestigious journals such as Blood, British Journal of Haematology and Current Medicinal Chemistry.

In The Last Decade

Eleonora Toffoletti

19 papers receiving 331 citations

Peers

Eleonora Toffoletti
Erica Simeone Italy
Frauke Bellos Germany
Ed Copelan United States
Rossana Putzulu Italy
Kathleen Glick United States
Patti Byron United States
Gianluca Barba Italy
Kiyomi Morita United States
Sandrine Le Noir France
Mariacarla De Simone Italy
Erica Simeone Italy
Eleonora Toffoletti
Citations per year, relative to Eleonora Toffoletti Eleonora Toffoletti (= 1×) peers Erica Simeone

Countries citing papers authored by Eleonora Toffoletti

Since Specialization
Citations

This map shows the geographic impact of Eleonora Toffoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Toffoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Toffoletti more than expected).

Fields of papers citing papers by Eleonora Toffoletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Toffoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Toffoletti. The network helps show where Eleonora Toffoletti may publish in the future.

Co-authorship network of co-authors of Eleonora Toffoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Toffoletti. A scholar is included among the top collaborators of Eleonora Toffoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Toffoletti. Eleonora Toffoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bernardi, Simona, Mirko Farina, Cristina Bucelli, et al.. (2024). Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study. Annals of Hematology. 104(1). 207–217. 5 indexed citations
2.
Franca, Raffaella, Claudio Sorio, Eleonora Toffoletti, et al.. (2021). A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias. Frontiers in Pharmacology. 12. 749361–749361. 4 indexed citations
3.
Toffoletti, Eleonora, Massimiliano Bonifacio, Gianni Binotto, et al.. (2020). BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC". Blood. 136(Supplement 1). 9–10. 1 indexed citations
4.
Domenis, Rossana, Maria ­Orsaria, Stefania Marzinotto, et al.. (2018). Expression and modulation of S100A4 protein by human mast cells. Cellular Immunology. 332. 85–93. 4 indexed citations
5.
6.
Candoni, Anna, Federico De Marchi, Maria Elena Zannier, et al.. (2017). High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission. Leukemia Research. 63. 22–27. 28 indexed citations
7.
Candoni, Anna, Federico De Marchi, Maria Elena Zannier, et al.. (2017). Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia. Experimental Hematology. 49. 25–33. 22 indexed citations
8.
Franca, Raffaella, Nataša Karas Kuželički, Claudio Sorio, et al.. (2017). Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia. Current Medicinal Chemistry. 25(24). 2811–2825. 6 indexed citations
9.
Boggio, Elena, Casimiro Luca Gigliotti, Davide Rossi, et al.. (2016). Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia. British Journal of Haematology. 176(2). 258–267. 8 indexed citations
10.
Damiani, Daniela, Mario Tiribelli, Donatella Raspadori, et al.. (2015). Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors. Oncotarget. 6(30). 30212–30221. 34 indexed citations
11.
Zaja, Francesco, Elena Boggio, Davide Rossi, et al.. (2014). Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Results of the Unit Study. Blood. 124(21). 1461–1461. 1 indexed citations
12.
Damiani, Daniela, Mario Tiribelli, Alessandra Franzoni, et al.. (2013). BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. American Journal of Hematology. 88(10). 848–852. 24 indexed citations
13.
Vago, Luca, Benedetta Mazzi, Raffaella Greco, et al.. (2013). High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants. Blood. 122(21). 3313–3313. 1 indexed citations
14.
Patriarca, Francesca, Marta Medeot, Miriam Isola, et al.. (2013). Prognostic factors and outcome of Epstein–Barr virus DNAemia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. Transplant Infectious Disease. 15(3). 259–267. 43 indexed citations
15.
Damiani, Daniela, Mario Tiribelli, Antonella Geromin, et al.. (2012). Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia. Annals of Hematology. 91(12). 1937–1943. 8 indexed citations
16.
17.
Patriarca, Francesca, Venerino Poletti, Ulrich Costabel, et al.. (2009). Clinical Presentation, Outcome and Risk Factors of Late-Onset Non- Infectious Pulmonary Complications After Allogeneic Stem Cell Transplantation. Current Stem Cell Research & Therapy. 4(2). 161–167. 12 indexed citations
18.
Candoni, Anna, Mario Tiribelli, Eleonora Toffoletti, et al.. (2008). Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. European Journal Of Haematology. 82(1). 61–68. 69 indexed citations
19.
Candoni, Anna, Giovanni Martinelli, Eleonora Toffoletti, et al.. (2008). Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years. Leukemia Research. 32(12). 1800–1808. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erica Simeone Breakdown of academic impact, for papers by Frauke Bellos Breakdown of academic impact, for papers by Ed Copelan Breakdown of academic impact, for papers by Rossana Putzulu Breakdown of academic impact, for papers by Kathleen Glick Breakdown of academic impact, for papers by Patti Byron Breakdown of academic impact, for papers by Gianluca Barba Breakdown of academic impact, for papers by Kiyomi Morita Breakdown of academic impact, for papers by Sandrine Le Noir Breakdown of academic impact, for papers by Mariacarla De Simone
Rankless by CCL
2026